vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $236.8M, roughly 1.1× CROSS COUNTRY HEALTHCARE INC). USANA HEALTH SCIENCES INC runs the higher net margin — 3.0% vs -35.0%, a 38.0% gap on every dollar of revenue. On growth, USANA HEALTH SCIENCES INC posted the faster year-over-year revenue change (-3.0% vs -23.6%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (11.8% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
CCRN vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $250.2M |
| Net Profit | $-82.9M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | -30.2% | 5.5% |
| Net Margin | -35.0% | 3.0% |
| Revenue YoY | -23.6% | -3.0% |
| Net Profit YoY | -2109.7% | -20.0% |
| EPS (diluted) | $-2.56 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $236.8M | $226.2M | ||
| Q3 25 | $250.1M | $213.7M | ||
| Q2 25 | $274.1M | $235.8M | ||
| Q1 25 | $293.4M | $249.5M | ||
| Q4 24 | $309.9M | $213.6M | ||
| Q3 24 | $315.1M | $200.2M | ||
| Q2 24 | $339.8M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $-82.9M | $180.0K | ||
| Q3 25 | $-4.8M | $-6.5M | ||
| Q2 25 | $-6.7M | $9.7M | ||
| Q1 25 | $-490.0K | $9.4M | ||
| Q4 24 | $-3.8M | $4.5M | ||
| Q3 24 | $2.6M | $10.6M | ||
| Q2 24 | $-16.1M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | 20.4% | 77.2% | ||
| Q2 25 | 20.4% | 78.7% | ||
| Q1 25 | 20.0% | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | 20.4% | 80.4% | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | -30.2% | 1.7% | ||
| Q3 25 | -2.4% | 0.6% | ||
| Q2 25 | -2.1% | 7.1% | ||
| Q1 25 | -0.3% | 6.3% | ||
| Q4 24 | -1.1% | 3.8% | ||
| Q3 24 | 0.9% | 7.8% | ||
| Q2 24 | -5.7% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | -35.0% | 0.1% | ||
| Q3 25 | -1.9% | -3.1% | ||
| Q2 25 | -2.4% | 4.1% | ||
| Q1 25 | -0.2% | 3.8% | ||
| Q4 24 | -1.2% | 2.1% | ||
| Q3 24 | 0.8% | 5.3% | ||
| Q2 24 | -4.7% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $-2.56 | $-0.10 | ||
| Q3 25 | $-0.15 | $-0.36 | ||
| Q2 25 | $-0.20 | $0.52 | ||
| Q1 25 | $-0.02 | $0.49 | ||
| Q4 24 | $-0.13 | $0.23 | ||
| Q3 24 | $0.08 | $0.56 | ||
| Q2 24 | $-0.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | — |
| Total Assets | $449.0M | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $108.7M | $158.4M | ||
| Q3 25 | $99.1M | $145.3M | ||
| Q2 25 | $81.2M | $151.3M | ||
| Q1 25 | $80.7M | $179.6M | ||
| Q4 24 | $81.6M | $181.8M | ||
| Q3 24 | $64.0M | $364.9M | ||
| Q2 24 | $69.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | $322.8M | — | ||
| Q3 25 | $408.1M | $528.1M | ||
| Q2 25 | $412.2M | $531.1M | ||
| Q1 25 | $418.2M | $529.8M | ||
| Q4 24 | $419.0M | $532.1M | ||
| Q3 24 | $424.7M | $533.1M | ||
| Q2 24 | $433.3M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $449.0M | $742.9M | ||
| Q3 25 | $538.2M | $726.6M | ||
| Q2 25 | $553.8M | $734.5M | ||
| Q1 25 | $576.2M | $746.6M | ||
| Q4 24 | $589.3M | $748.2M | ||
| Q3 24 | $597.4M | $671.3M | ||
| Q2 24 | $602.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | — | ||
| Q3 25 | $20.1M | $-2.0M | ||
| Q2 25 | $4.2M | $12.2M | ||
| Q1 25 | $5.7M | $15.5M | ||
| Q4 24 | $24.2M | $5.8M | ||
| Q3 24 | $7.5M | $29.5M | ||
| Q2 24 | $82.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | $-5.2M | ||
| Q2 25 | $2.3M | $7.2M | ||
| Q1 25 | $3.8M | $12.7M | ||
| Q4 24 | $21.7M | $4.0M | ||
| Q3 24 | $6.3M | $27.1M | ||
| Q2 24 | $79.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | -2.4% | ||
| Q2 25 | 0.8% | 3.0% | ||
| Q1 25 | 1.3% | 5.1% | ||
| Q4 24 | 7.0% | 1.9% | ||
| Q3 24 | 2.0% | 13.6% | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | 1.5% | ||
| Q2 25 | 0.7% | 2.1% | ||
| Q1 25 | 0.6% | 1.1% | ||
| Q4 24 | 0.8% | 0.8% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | 2.92× | 2.78× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
USNA
Segment breakdown not available.
